EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Impact on mortality and incidence of end-stage renal disease of education and treatment at a diabetes center among patients with type 1 diabetes: comparison of two subgroups in the Japanese DERI cohort



Impact on mortality and incidence of end-stage renal disease of education and treatment at a diabetes center among patients with type 1 diabetes: comparison of two subgroups in the Japanese DERI cohort



Journal of Diabetes and Its Complications 18(3): 155-159



The aim of this study was to compare mortality and incidence of end-stage renal disease (ESRD) in patients with type 1 (insulin-dependent) diabetes who had attended a diabetes center with those who had not. The cohort consisted of a total of 1430 patients diagnosed with Type 1 diabetes at 18 years or younger, and between 1965 and 1979. This population-based cohort in Japan was subdivided into two groups: patients who had visited a large diabetes center in Tokyo (n = 162) and those who had not (n = 1212). Mortality and incidence of ESRD were compared between the two subgroups as of January 1, 1990. Crude mortality was 1.95 per 1000 person-years (95% CI: 0.49-5.06) for those who had visited the center and 6.05 (4.86-7.41) for those who had not. A multivariate Cox proportional hazard model showed that the patients who had visited the center were three times less likely to die (hazard ratio: 0.31, 95% CI: 0.10-0.98) than those who had not. Crude incidence of ESRD was 1.32 (0.22-4.09) and 5.86 (4.65-7.26) for those who had visited the center and for those who had not, respectively. After adjusting for covariates, the patients who had visited the center were five times less likely to develop ESRD (hazard ratio: 0.19, 0.05-0.78) than those who had not. Education and treatment of type 1 diabetes with an integrated management system under specialists and a multidisciplinary team appears to be associated with a better prognosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 012184773

Download citation: RISBibTeXText

PMID: 15145326

DOI: 10.1016/j.jdiacomp.2003.10.002



Related references

Comparison of mortality and end-stage renal disease between patients in one diabetes center and others in Japanese DERI cohort. Diabetologia 43(Supplement 1): A256, August, 2000

Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Diabetologia 38(2): 236-243, 1995

The Impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders. Nephron. Clinical Practice 112(4): C268-C275, 2009

The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy. Pharmacoeconomics 24(6): 549-558, 2006

Incidence of end stage renal disease among type 1 diabetes: a nationwide cohort study in Taiwan. Medicine 93(28): E274-E274, 2015

Causes of death in patients with childhood-onset type 1 diabetes receiving dialysis in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study. Journal of Diabetes and Its Complications 29(7): 903-907, 2016

Cause-specific mortality trends in a nationwide population-based cohort of childhood-onset type 1 diabetes in Japan during 35 years of follow-up: the DERI Mortality Study. Diabetologia 56(10): 2171-2175, 2014

Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes. Diabetes Care, 2017

Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294(14): 1782-1787, 2005

The impact of renal transplantation on the incidence of bacterial septicemia in patients with end stage renal disease due to diabetes. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 873A, September, 2001

The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes. Journal of Nephrology 14(5): 369-376, 2001

Effect of intrauterine diabetes exposure on the incidence of end-stage renal disease in young adults with type 2 diabetes. Diabetes Care 33(11): 2396-2398, 2011

Age at Transition from Pediatric to Adult Care Has No Relationship with Mortality for Childhood-Onset Type 1 Diabetes in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study. Plos One 11(3): E0150720-E0150720, 2016

Body mass index and mortality among Japanese patients with type 2 diabetes: pooled analysis of the Japan diabetes complications study and the Japanese elderly diabetes intervention trial. Journal of Clinical Endocrinology and Metabolism 99(12): E2692-6, 2015

Incidence of end-stage renal disease in patients with type 1 diabetes was 7.8% at 30 years after diagnosis. Acp Journal Club 144(2): 51-51, 2006